Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Severe atypical endometrial changes and sequential contraceptive use

R H Kaufman, K O Reeves, C M Dougherty

    JAMA
    |August 23, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Detection of chromosomal aberrations by fluorescence in situ hybridization in cervicovaginal biopsies from women exposed to diethylstilbestrol in utero.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2006
    Same author

    Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: expression of coxsackie-adenovirus receptor and integrins alphavbeta3 and alphavbeta5.

    Journal of the Society for Gynecologic Investigation·2002
    Same author

    Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancer.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2002
    Same author

    Adenovirus-mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-year follow-up.

    Gynecologic oncology·2001
    Same author

    Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States).

    Cancer causes & control : CCC·2001
    Same author

    Is there a role for human papillomavirus testing in clinical practice?

    Obstetrics and gynecology·2001
    Same journal

    Alcohol-Related Liver Disease: A Review.

    JAMA·2026
    Same journal

    Online Prescribing of GLP-1 Receptor Agonists.

    JAMA·2026
    Same journal

    Using AI Disagreement to Expose Gaps in Coverage Rules.

    JAMA·2026
    Same journal

    Randomized Trials in Pregnancy.

    JAMA·2026
    Same journal

    Randomized Trials in Pregnancy-Reply.

    JAMA·2026
    Same journal

    WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

    JAMA·2026
    See all related articles

    This study observed endometrial cancer in young women using dimethisterone-ethinyl estradiol (Oracon) sequential contraceptives. While not definitive proof, these findings suggest a potential link between long-term use and endometrial adenocarcinoma or atypia.

    Area of Science:

    • Reproductive Endocrinology
    • Gynecologic Oncology

    Background:

    • Endometrial carcinoma typically affects postmenopausal women.
    • Young women developing endometrial cancer are uncommon.
    • Hormonal contraceptive use is a known factor in gynecologic health.

    Purpose of the Study:

    • To investigate a potential association between sequential oral contraceptive use and endometrial pathologies in young women.
    • To report on a series of cases of endometrial adenocarcinoma and atypical hyperplasia in young patients.

    Main Methods:

    • Retrospective case review of eight young women.
    • Analysis of patient demographics, medical history, and contraceptive use.
    • Histopathological examination of endometrial tissue.

    Related Experiment Videos

    Main Results:

    • Seven patients diagnosed with well-differentiated endometrial adenocarcinoma.
    • One patient diagnosed with atypical endometrial hyperplasia.
    • Average patient age was 40.1 years.
    • Average duration of dimethisterone-ethinyl estradiol (Oracon) use was 6.04 years.

    Conclusions:

    • The observed cases are atypical for typical endometrial carcinoma development.
    • Long-term administration of dimethisterone-ethinyl estradiol may be associated with endometrial adenocarcinoma or atypia.
    • Further research is warranted to establish causality.